347 related articles for article (PubMed ID: 32828550)
1. Host Polymorphisms May Impact SARS-CoV-2 Infectivity.
Brest P; Refae S; Mograbi B; Hofman P; Milano G
Trends Genet; 2020 Nov; 36(11):813-815. PubMed ID: 32828550
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
Milne S; Yang CX; Timens W; Bossé Y; Sin DD
Lancet Respir Med; 2020 Jun; 8(6):e50-e51. PubMed ID: 32411576
[No Abstract] [Full Text] [Related]
4. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
Alshahawey M; Raslan M; Sabri N
Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
[No Abstract] [Full Text] [Related]
5. Expression Pattern of the SARS-CoV-2 Entry Genes
Liu Y; Qu HQ; Qu J; Tian L; Hakonarson H
Viruses; 2020 Oct; 12(10):. PubMed ID: 33081421
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
[No Abstract] [Full Text] [Related]
7. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
8. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG
Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 challenging cell biology.
Bullerdiek J
Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
[No Abstract] [Full Text] [Related]
11. Could angiotensin-converting enzyme 1
Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
[No Abstract] [Full Text] [Related]
12. Genetic predisposition models to COVID-19 infection.
Darbeheshti F; Rezaei N
Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
[No Abstract] [Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.
Wambier CG; Goren A
J Am Acad Dermatol; 2020 Jul; 83(1):308-309. PubMed ID: 32283245
[TBL] [Abstract][Full Text] [Related]
14. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
[No Abstract] [Full Text] [Related]
15. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.
Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM
Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249
[TBL] [Abstract][Full Text] [Related]
16. Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.
Choudhary S; Sreenivasulu K; Mitra P; Misra S; Sharma P
Ann Lab Med; 2021 Mar; 41(2):129-138. PubMed ID: 33063674
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML
Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944
[TBL] [Abstract][Full Text] [Related]
18. Gene expression and
Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
[TBL] [Abstract][Full Text] [Related]
19. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
Sajuthi SP; DeFord P; Li Y; Jackson ND; Montgomery MT; Everman JL; Rios CL; Pruesse E; Nolin JD; Plender EG; Wechsler ME; Mak ACY; Eng C; Salazar S; Medina V; Wohlford EM; Huntsman S; Nickerson DA; Germer S; Zody MC; Abecasis G; Kang HM; Rice KM; Kumar R; Oh S; Rodriguez-Santana J; Burchard EG; Seibold MA
Nat Commun; 2020 Oct; 11(1):5139. PubMed ID: 33046696
[TBL] [Abstract][Full Text] [Related]
20. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F
Clin Chem Lab Med; 2020 Aug; 58(9):1415-1422. PubMed ID: 32598305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]